SCH 527123
SCH 527123
To Order Contact us: caitlyn@ucb-bioproducts.com
 Sch 38519 |
|||
| S078-0.5MG | TOKU-E | 0.5 mg | EUR 318 |
Sch 38519 |
|||
| S078-2.5MG | TOKU-E | 2.5 mg | EUR 1040 |
 Sch 725674 |
|||
| S079-1MG | TOKU-E | 1 mg | EUR 318 |
Sch 725674 |
|||
| S079-5MG | TOKU-E | 5 mg | EUR 1040 |
 SCH 58261 |
|||
| HY-19533 | MedChemExpress | 5mg | EUR 160 |
 SCH-1473759 |
|||
| HY-10482 | MedChemExpress | 100mg | EUR 1634 |
 SCH 563705 |
|||
| HY-10011 | MedChemExpress | 10mM/1mL | EUR 391 |
 SCH 546738 |
|||
| HY-10017 | MedChemExpress | 50mg | EUR 2116 |
 SCH 221510 |
|||
| B7326-10 | ApexBio | 10 mg | EUR 389 |
SCH 221510 |
|||
| B7326-50 | ApexBio | 50 mg | EUR 1476 |
SCH 563705 |
|||
| A3803-10 | ApexBio | 10 mg | EUR 706 |
|
Description: SCH 563705, a potent CXCR2 and CXCR1 antagonist, has therapeutic potential for targeting CXCR2/CXCR1 in human arthritides. |
|||
SCH 563705 |
|||
| A3803-5 | ApexBio | 5 mg | EUR 528 |
|
Description: SCH 563705, a potent CXCR2 and CXCR1 antagonist, has therapeutic potential for targeting CXCR2/CXCR1 in human arthritides. |
|||
SCH 563705 |
|||
| A3803-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 498 |
|
Description: SCH 563705, a potent CXCR2 and CXCR1 antagonist, has therapeutic potential for targeting CXCR2/CXCR1 in human arthritides. |
|||
SCH-1473759 |
|||
| A3804-10 | ApexBio | 10 mg | EUR 628 |
|
Description: IC50 Value: 4 nM (IC50) for Aurora A, and below or equal to 13 nM (IC50) for Aurora B [1]. SCH 1473759, a novel sub-nanomolar Aurora A/B inhibitor. |
|||
SCH-1473759 |
|||
| A3804-100 | ApexBio | 100 mg | EUR 2130 |
|
Description: IC50 Value: 4 nM (IC50) for Aurora A, and below or equal to 13 nM (IC50) for Aurora B [1]. SCH 1473759, a novel sub-nanomolar Aurora A/B inhibitor. |
|||
SCH-1473759 |
|||
| A3804-2 | ApexBio | 2 mg | EUR 267 |
|
Description: IC50 Value: 4 nM (IC50) for Aurora A, and below or equal to 13 nM (IC50) for Aurora B [1]. SCH 1473759, a novel sub-nanomolar Aurora A/B inhibitor. |
|||
SCH-1473759 |
|||
| A3804-5 | ApexBio | 5 mg | EUR 448 |
|
Description: IC50 Value: 4 nM (IC50) for Aurora A, and below or equal to 13 nM (IC50) for Aurora B [1]. SCH 1473759, a novel sub-nanomolar Aurora A/B inhibitor. |
|||
SCH-1473759 |
|||
| A3804-50 | ApexBio | 50 mg | EUR 1407 |
|
Description: IC50 Value: 4 nM (IC50) for Aurora A, and below or equal to 13 nM (IC50) for Aurora B [1]. SCH 1473759, a novel sub-nanomolar Aurora A/B inhibitor. |
|||
 SCH 51344 |
|||
| B4935-10 | ApexBio | 10 mg | EUR 238 |
|
Description: Kd: 49 nMSCH 51344 is a potent MTH1 inhibitor. MTH1, also known as NUDT1, is a nucleotide pool sanitizing enzyme. Loss-of-function of MTH1 impaired growth of KRAS tumour cells. |
|||
SCH 51344 |
|||
| B4935-5 | ApexBio | 5 mg | EUR 154 |
|
Description: Kd: 49 nMSCH 51344 is a potent MTH1 inhibitor. MTH1, also known as NUDT1, is a nucleotide pool sanitizing enzyme. Loss-of-function of MTH1 impaired growth of KRAS tumour cells. |
|||
SCH 51344 |
|||
| B4935-50 | ApexBio | 50 mg | EUR 937 |
|
Description: Kd: 49 nMSCH 51344 is a potent MTH1 inhibitor. MTH1, also known as NUDT1, is a nucleotide pool sanitizing enzyme. Loss-of-function of MTH1 impaired growth of KRAS tumour cells. |
|||
 SCH 50911 |
|||
| B5040-10 | ApexBio | 10 mg | EUR 373 |
SCH 50911 |
|||
| B5040-50 | ApexBio | 50 mg | EUR 1413 |
 SCH 529074 |
|||
| B5544-10 | ApexBio | 10 mg | EUR 311 |
SCH 529074 |
|||
| B5544-25 | ApexBio | 25 mg | EUR 659 |
SCH 529074 |
|||
| B5544-5 | ApexBio | 5 mg | EUR 206 |
 SCH 28080 |
|||
| B6832-10 | ApexBio | 10 mg | EUR 241 |
SCH 28080 |
|||
| B6832-5 | ApexBio | 5 mg | EUR 163 |
SCH 28080 |
|||
| B6832-50 | ApexBio | 50 mg | EUR 920 |
SCH 58261 |
|||
| B6995-10 | ApexBio | 10 mg | EUR 286 |
SCH 58261 |
|||
| B6995-50 | ApexBio | 50 mg | EUR 1044 |
 SCH 442416 |
|||
| B7065-10 | ApexBio | 10 mg | EUR 293 |
SCH 442416 |
|||
| B7065-25 | ApexBio | 25 mg | EUR 615 |
SCH 442416 |
|||
| B7065-5 | ApexBio | 5 mg | EUR 197 |
) SCH 23390 (hydrochloride) |
|||
| HY-19545A | MedChemExpress | 25mg | EUR 340 |
) SCH-1473759 (hydrochloride) |
|||
| HY-10483 | MedChemExpress | 10mM/1mL | EUR 359 |
 Sch-42495 racemate |
|||
| HY-101682A | MedChemExpress | 1mg | EUR 1125 |
 SCH Conjugated Antibody |
|||
| C29067 | SAB | 100ul | EUR 397 |
 SCH 23390 hydrochloride |
|||
| B6506-10 | ApexBio | 10 mg | EUR 209 |
SCH 23390 hydrochloride |
|||
| B6506-50 | ApexBio | 50 mg | EUR 650 |
 SCH 202676 hydrobromide |
|||
| B6722-10 | ApexBio | 10 mg | EUR 179 |
SCH 202676 hydrobromide |
|||
| B6722-25 | ApexBio | 25 mg | EUR 357 |
SCH 202676 hydrobromide |
|||
| B6722-5 | ApexBio | 5 mg | EUR 118 |
SCH 202676 hydrobromide |
|||
| B6722-50 | ApexBio | 50 mg | EUR 595 |
 SCH 79797 dihydrochloride |
|||
| B6801-10 | ApexBio | 10 mg | EUR 238 |
SCH 79797 dihydrochloride |
|||
| B6801-5 | ApexBio | 5 mg | EUR 186 |
 SCH 39166 hydrobromide |
|||
| B7006-10 | ApexBio | 10 mg | EUR 383 |
SCH 39166 hydrobromide |
|||
| B7006-50 | ApexBio | 50 mg | EUR 1455 |
 CH2 domain scaffold protein anti-Human Her2 |
|||
| SCH-L060 | Creative Biolabs | 1 mg | EUR 4496 |
|
Description: Scaffold protein |
|||
) MK-8776 (SCH-900776) |
|||
| A8477-10 | ApexBio | 10 mg | EUR 235 |
|
Description: SCH 900776 is a potent and selective inhibitor of cell cycle checkpoint kinase 1 (Chk1), Chk2 and Cdk3 with IC50 value of 3 nM, 1.5µM and 0.16 µM, respectively. |
|||
MK-8776 (SCH-900776) |
|||
| A8477-5 | ApexBio | 5 mg | EUR 177 |
|
Description: SCH 900776 is a potent and selective inhibitor of cell cycle checkpoint kinase 1 (Chk1), Chk2 and Cdk3 with IC50 value of 3 nM, 1.5µM and 0.16 µM, respectively. |
|||
MK-8776 (SCH-900776) |
|||
| A8477-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 190 |
|
Description: SCH 900776 is a potent and selective inhibitor of cell cycle checkpoint kinase 1 (Chk1), Chk2 and Cdk3 with IC50 value of 3 nM, 1.5µM and 0.16 µM, respectively. |
|||
MK-8776 (SCH-900776) |
|||
| A8477-50 | ApexBio | 50 mg | EUR 572 |
|
Description: SCH 900776 is a potent and selective inhibitor of cell cycle checkpoint kinase 1 (Chk1), Chk2 and Cdk3 with IC50 value of 3 nM, 1.5µM and 0.16 µM, respectively. |
|||